Abstract

Primary cardiomyopathies (CMPs) are monogenic but multi-allelic disorders with dozens of genes involved in pathogenesis. The implementation of next-generation sequencing (NGS) approaches has resulted in more time- and cost-efficient DNA diagnostics of cardiomyopathies. However, the diagnostic yield of genetic testing for each subtype of CMP fails to exceed 60%. The aim of this study was to demonstrate that allelic dropout (ADO) is a common phenomenon that reduces the diagnostic yield in primary cardiomyopathy genetic testing based on targeted gene panels assayed on the Ion Torrent platform. We performed mutational screening with three custom targeted gene panels based on sets of oligoprimers designed automatically using AmpliSeq Designer® containing 1049 primer pairs for 37 genes with a total length of 153 kb. DNA samples from 232 patients were screened with at least one of these targeted gene panels. We detected six ADO events in both IonTorrent PGM (three cases) and capillary Sanger sequencing (three cases) data, identifying ADO-causing variants in all cases. All ADO events occurred due to common or rare single nucleotide variants (SNVs) in the oligoprimer binding sites and were detected because of the presence of “marker” SNVs in the target DNA fragment. We ultimately identified that PCR-based NGS involves a risk of ADO that necessitates the use of Sanger sequencing to validate NGS results. We assume that oligoprimer design without ADO data affects the amplification efficiency of up to 0.77% of amplicons.

Highlights

  • In recent years, the study of the genetic causes of monogenic diseases has evolved from a basic science research area into widely accepted clinical testing protocols with substantial impacts on diagnostics and clinical decision-making (Ackerman et al, 2011)

  • We found that three allelic dropout (ADO) cases occurred during sequencing on the IonTorrent platform and three occurred during capillary Sanger sequencing

  • ADO is a known limitation of polymerase chain reaction (PCR)-based molecular diagnostic approaches

Read more

Summary

Introduction

The study of the genetic causes of monogenic diseases has evolved from a basic science research area into widely accepted clinical testing protocols with substantial impacts on diagnostics and clinical decision-making (Ackerman et al, 2011). Primary cardiomyopathies (CMP) are monogenic but multi-allelic disorders with dozens of genes involved in pathogenesis (Hershberger et al, 2018). The implementation of NGS approaches has resulted in more time- and cost-efficient DNA diagnostics of cardiomyopathies. The diagnostic yield of genetic testing for each subtype of CMP fails to exceed 60% (Hershberger et al, 2018). The technical limitations of all known techniques of DNA/RNA analysis and variant interpretation contribute to incomplete results. Alternative sequencing approaches such as capillary Sanger sequencing confirm the genetic variants found by NGS methods to increase the reliability of the DNA test results (Baudhuin et al, 2015)

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call